GlassScriptPhysician profile
Prakash B Patel
NPI 1730187808
$2,201.66
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $591 · 2021: $1,177 · 2022: $29.07.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $476.60 | 2019-2021 | |
| Janssen Biotech, INC. | $460.34 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $167.51 | 2019-2021 | |
| Myovant Sciences INC. | $165.74 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.04 | 2020-2022 | |
| Sirtex Medical INC | $143.11 | 2019 | |
| Boston Scientific Corporation | $136.65 | 2019-2021 | |
| Kyowa Kirin, INC. | $116.08 | 2019-2021 | |
| Genzyme Corporation | $57.36 | 2021 | |
| Amgen INC. | $50.07 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $37.60 | 2019 | |
| Daiichi Sankyo INC. | $32.63 | 2021 | |
| Pharmacosmos Therapeutics INC. | $28.00 | 2021 | |
| Lilly USA, LLC | $24.10 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $21.04 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $16.40 | 2021 | |
| Mylan Institutional INC. | $16.15 | 2019 | |
| Pfizer INC. | $15.75 | 2021 | |
| Aveo Pharmaceuticals, INC. | $15.39 | 2021 | |
| Emd Serono, INC. | $14.97 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.94 | 2019 | |
| Abbvie INC. | $11.59 | 2021 | |
| Seagen INC. | $11.52 | 2020 | |
| Gilead Sciences, INC. | $11.08 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prakash Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.